Purchase Order 68HE0B26P0075
- Not listed
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., was awarded a $35,251.50 firm fixed-price purchase order by the Office of Research and Development (a civilian federal agency) on November 21, 2025, for laboratory supplies consisting of reagents for quantitative polymerase chain reaction (qPCR) analysis. The contract is designated as a child award with an ultimate completion date of November 20, 2026, and will be performed in Washington, DC. No small business...
- Life Technologies Corporation (doing business as Thermo Fisher Scientific) was awarded a Blanket Purchase Agreement (BPA) call contract valued at $12,460 by the Office of Logistics and Acquisition Operations, a civilian federal agency, on January 6, 2017, with an ultimate completion date of April 30, 2017. The contract is for drugs and biologicals under a firm fixed-price arrangement with no set-aside designation. Performance will take place in Grand Island, New York. This award represents a...
- This is a firm-fixed-price purchase order awarded by the U.S. Department of Health and Human Services (HHS) to Life Technologies Corporation, now part of Thermo Fisher Scientific Inc., for the delivery of lab supplies with a potential value of $1,395,000.00. The contract does not have a set-aside designation. Life Technologies is a leading provider of tools and technologies for biomedical research and genetic analysis to government agencies and academic institutions. The company has supplied...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a $4,795 firm fixed price contract award from the National Center for Advancing Translational Sciences on December 8, 2014, with an ultimate completion date of April 30, 2015. This award was issued as a Blanket Purchase Agreement (BPA) call with no set-aside designation, reflecting the contractor's competitive positioning in federal scientific procurement. The contract concerns LanthaScreen assays for Menghang...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The $147,500 firm fixed-price purchase order is for "TAQMAN SPECIAL GENE-EX CARDS, LAB SUPPLIES" to be delivered by October 30, 2015. The contract does not have a set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools,...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $3,919.80 firm fixed-price Blanket Purchase Agreement (BPA) call by the National Institute of Environmental Health Sciences (NIEHS) on September 6, 2016, with an ultimate completion date of April 30, 2017. The contract was performed in Grand Island, New York, and no set-aside designation was utilized in this procurement. This award represents a task order under an existing BPA vehicle, through which Life...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a contract award on December 7, 2016, from the Office of Logistics and Acquisition Operations (a civilian federal agency) for $5,360.60 under a Blanket Purchase Agreement (BPA) call. The award was made on a firm fixed-price basis without a set-aside designation and is scheduled for completion by December 14, 2016. The contract will be performed in Carlsbad, California. As a leading provider of scientific...
- This federal contract award to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, is for the delivery of consumable supplies. The $13,758.27 firm fixed-price delivery order was placed by a civilian federal agency, the Northeast Area of the agency with the ID 1200|12H2|VPARSFRIIDNEA-A. There was no set-aside used for this award. Life Technologies has established itself as a key supplier of scientific instruments, reagents, and consumables to various federal agencies,...
- This federal contract award to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, is for the delivery of 4387391 - AGPATH-ID ONE-STEP RT-PCR (1000 RXN) products. The $77,130.57 firm fixed price contract was awarded on September 11, 2020 by the Northeast Area office of a civilian federal agency. The award does not utilize any set-aside designations. Life Technologies Corporation has a history of providing a range of scientific instruments, reagents, and services to support...
- This is a $17,273.60 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract provides for the procurement of life sciences research reagents, with an ultimate completion date of May 21, 2025. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies, specializing in delivering a...
Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. and headquartered in Grand Island, New York, has been awarded a $19,550.44 firm fixed-price purchase order for TaqMan lab supplies by the Office of Research and Development. The award was made on December 8, 2025, with an ultimate completion date of January 30, 2026. This non-set-aside contract represents a child award, likely issued under one of Life Technologies' existing indefinite delivery vehicles with federal agencies. The place of performance is Grand Island, New York, aligning with the contractor's primary operational location. Life Technologies Corporation is a critical supplier of biomedical research tools and genetic analysis technologies to federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, Food and Drug Administration, and Department of Agriculture. The company maintains significant indefinite delivery contracts with the Veterans Affairs system for genome reagents and sequencing products that support precision medicine initiatives. TaqMan reagents are molecular biology products commonly used in quantitative polymerase chain reaction (qPCR) applications for genetic analysis, disease detection, and research purposes, aligning with the company's core portfolio of specialized scientific consumables and diagnostic tools for government life sciences research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.6k | 12/8/25 |